Biotech R&D Tax Credit Ohio for Life Sciences


Biotechnology and life sciences companies often perform laboratory, diagnostic, product development, and bioprocess work that may support an R&D Tax Credit review. The biotech R&D tax credit Ohio opportunity depends on the technical activities performed, the uncertainty involved, the experimentation used to evaluate alternatives, and the documentation connecting qualified work to eligible expenses.

Quick answer: Biotech and life sciences companies may qualify when they conduct documented technical research to develop or improve diagnostics, laboratory methods, biological processes, formulations, medical technologies, or related software. Routine quality control, regulatory administration, market research, and work performed after technical uncertainty has been resolved generally need to be separated.


Since 2004, RCG has completed more than 25,000 R&D tax credit studies and identified over $750 million in tax savings. RCG’s team includes CPAs, tax specialists, engineers, technical writers, and architects who support federal and state R&D Tax Credit studies with audit-ready documentation.


RCG provides R&D Tax Credit support for biotechnology and life sciences businesses across Ohio, including companies in Cleveland, Columbus, Cincinnati, Dayton, and surrounding research, healthcare, laboratory, and technology communities.

Cost Segregation may apply to many property types, including warehouses, manufacturing facilities, medical offices, dental offices, office buildings, industrial properties, retail spaces, and mixed-use commercial properties.

What Biotech Activities May Qualify for the R&D Tax Credit?

Biotech companies may need an R&D review when projects involve uncertainty related to capability, method, design, performance, reliability, or quality. Potential activities can include laboratory method development, diagnostic testing, formulation work, bioprocess refinement, assay development, prototype medical technologies, and technical software.

Life sciences activity Why it may need R&D review
Diagnostic development May involve testing sensitivity, accuracy, reliability, or technical methods.
Laboratory method development May involve evaluating procedures, materials, equipment settings, or analytical approaches.
Bioprocess refinement May involve testing yield, consistency, scalability, stability, or process control.
Formulation development May involve evaluating ingredient interactions, performance, stability, or delivery methods.
Technical software development May involve improving data processing, laboratory automation, analysis, or system integration.

These activities do not automatically qualify. Each business component should be evaluated based on its technical objective, uncertainty, experimentation, documentation, and related expenses.

Laboratory Research Tax Credit Considerations

A laboratory research tax credit review should focus on the purpose and structure of the work. Laboratory testing may be relevant when it is used to evaluate alternatives or resolve uncertainty during development.

Routine testing that confirms established specifications may not receive the same treatment. Standard quality control, production inspection, regulatory recordkeeping, and repeated testing after the technical issue has been resolved generally need to be separated from experimental research.

The analysis should explain what the company sought to discover, which alternatives were tested, how results were evaluated, and how the findings affected the next technical decision.

Diagnostic Development and Bioprocess Research

A diagnostic development tax credit review may involve work on testing methods, detection systems, analytical performance, sample handling, accuracy, reliability, or technical integration. Eligibility depends on the development activity, not simply whether a product is used in healthcare.

A bioprocess tax credit review may involve technical work related to production yield, purification, consistency, contamination control, scalability, stability, or process monitoring. Routine production and standard operating procedures generally need to be distinguished from work performed while technical uncertainty remained.

Documentation for Biotech R&D Credit Claims

Biotechnology and life sciences projects often generate extensive records, but those records still need to connect technical activity to specific business components and qualified expenses.

Useful documentation may include laboratory notes, test protocols, experimental results, formulation records, process development records, design revisions, technical reports, project timelines, employee time support, material records, and technical meeting notes.

Strong documentation should identify:

  • The technical uncertainty being addressed
  • The alternatives evaluated
  • The experimentation performed
  • The employees and expenses connected to the work
  • The results and resulting technical decisions


General research descriptions are usually less useful than project-specific records showing what was tested and why.

What Expenses May Need Review?

Qualified research expenses may include certain employee wages, supplies used in qualified research, and eligible contract research expenses. The treatment of each cost depends on the activity performed and the supporting records.

For life sciences companies, potential supply costs may include nondepreciable materials consumed during qualifying laboratory experiments, test batches, formulation trials, or prototype development. Routine production materials, general administrative expenses, and depreciable property generally require different treatment.

FAQs About Biotech R&D Tax Credits in Ohio

  • Can biotech companies in Ohio claim the R&D Tax Credit?

    Biotech companies may qualify when they perform documented technical research involving uncertainty and experimentation. Eligibility depends on the project facts, business components, expenses, and supporting records.

  • Does laboratory testing qualify?

    Laboratory testing may qualify when it is performed to resolve technical uncertainty or evaluate alternatives during development. Routine quality control or testing against established specifications generally needs to be separated.

  • Can diagnostic development qualify?

    Diagnostic development may need review when it involves technical experimentation related to accuracy, sensitivity, reliability, methods, sample handling, or system performance.

  • Does bioprocess improvement qualify?

    Bioprocess improvements may qualify when teams test alternatives to improve yield, consistency, scalability, stability, or process performance. Routine production changes do not automatically qualify.

  • What records support a biotech R&D claim?

    Helpful records may include laboratory notes, test protocols, experimental results, process records, formulation logs, project timelines, technical reports, employee time support, and material records.

Review Your Ohio Life Sciences R&D Activity

The biotech R&D tax credit Ohio opportunity may apply to companies conducting documented laboratory research, diagnostic development, formulation testing, bioprocess improvement, or technical software development. Eligibility requires project-specific review and supportable documentation.


RCG Tax Partners provides technical analysis and audit-ready support for federal and state R&D Tax Credit studies.

RECENT BLOGS

By RCG Tax Partners • September 11, 2026
Learn how 100% bonus depreciation and cost segregation may affect Ohio commercial property owners in 2026. See what property may qualify.
By RCG Tax Partners • September 8, 2026
Learn how cost segregation may apply after buying an existing commercial property in Ohio, including basis allocation and depreciation review.
By RCG Tax Partners • September 4, 2026
Learn which Ohio building projects may still qualify for Section 179D after June 30, 2026 and what construction-start timing means.
By RCG Tax Partners • September 2, 2026
Learn what Form 6765 Section G requires in 2026 for Ohio R&D credit claimants, including business-component reporting and key exceptions.
By RCG Tax Partners • September 1, 2026
Learn when look-back cost segregation in Ohio may use Form 3115 and a Section 481(a) adjustment to address missed depreciation.
By RCG Tax Partners • August 21, 2026
Medical device companies often perform technical work that may support an R&D Tax Credit review. The medical device R&D tax credit Ohio opportunity may apply when a company develops or improves devices, components, firmware, materials, manufacturing processes, or testing methods through documented technical experimentation. Quick answer: Medical device companies may qualify when teams evaluate technical alternatives related to device function, performance, reliability, quality, manufacturability, materials, software, or production methods. Eligibility depends on project-specific facts, qualified expenses, and documentation. Routine quality control, regulatory administration, and testing performed after technical uncertainty has been resolved generally need to be separated. Since 2004, RCG has completed more than 25,000 R&D tax credit studies and identified over $750 million in tax savings. RCG’s team includes CPAs, tax specialists, engineers, technical writers, and architects who support federal and state R&D Tax Credit studies with audit-ready documentation. RCG provides R&D Tax Credit support for medical device and medtech companies across Ohio, including businesses in Cleveland, Beachwood, Columbus, Dublin, Cincinnati, Blue Ash, Dayton, and surrounding healthcare technology and manufacturing communities.

SHARE THIS